XML 44 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity
12 Months Ended
Dec. 31, 2011
Stockholders' Equity [Abstract]  
Stockholders' Equity

7. STOCKHOLDERS' EQUITY

Preferred stock

The Company is authorized to issue 50 million shares of preferred stock, with a par value of $0.0001. There are no shares of preferred stock outstanding as of December 31, 2011.

Stock Purchase Warrants

On January 1, 2009, the Company adopted new provisions of ASC 815, Derivatives and Hedging. The Company applied the newly adopted provisions of ASC 815 to its outstanding stock purchase warrants, which resulted in a $14.7 million reduction in additional paid-in capital offset by a $14.0 million reduction in the deficit and established a share-based payment liability of $675. ASC 815 requires the Company to adjust the share-based payment liability to the fair value each reporting period. The fair value adjustment for the stock purchase warrants did not materially affect net loss or loss per share in the consolidated statement of operations for the years ended December 31, 2011, 2010, or 2009.

 

The following table and related information summarizes the Company's stock purchase warrants at December 31, 2011 and the stock purchase warrant activity for the three years ended December 31, 2011, 2010 and 2009:

 

     Number
Outstanding
    Weighted-Average
Exercise Price
per Share
 

Warrants outstanding at December 31, 2008

     21,067,637      $ 2.99   

Expired

     (298 )      2.25   
  

 

 

   

 

 

 

Warrants outstanding at December 31, 2009

     21,067,339      $ 2.99   

Expired

     (2,175,243 )      2.93   
  

 

 

   

 

 

 

Warrants outstanding at December 31, 2010

     18,892,096      $ 2.99   

Expired

     (3,299,996 )      2.31   
  

 

 

   

 

 

 

Warrants outstanding at December 31, 2011

     15,592,100      $ 3.14   
  

 

 

   

 

 

 

The Company recorded compensation expense of $0 relating to vesting of grants [2010—$0, 2009—$1]. The Company also recorded $(129) in 2011 [2010—$(662), 2009—$116] for the change in the fair value of the warrants that have exercise prices that are denominated in Canadian dollars.

The warrants outstanding at December 31, 2011 expire as follows: 10,800,000 March 2012 and 4,792,100 April 2012.